NIOX Group Plc (CSSPF)

Market Cap	358.53M -10.4%
Revenue (ttm)	65.55M +24.9%
Net Income	9.42M -40.2%
EPS	0.02 -36.7%
Shares Out	n/a
PE Ratio	38.06
Forward PE	26.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.8200
Previous Close	n/a
Day's Range	0.8200 - 0.8200
52-Week Range	0.7500 - 0.8200
Beta	-0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2026

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Pl...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 97
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSSPF

Financial Performance

In 2025, NIOX Group's revenue was 48.70 million, an increase of 16.51% compared to the previous year's 41.80 million. Earnings were 7.00 million, an increase of 89.19%.

Financial numbers in GBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 11, 2026

Data Sources Report a data error